Published in Blood Weekly, August 7th, 2003
Research funded by Geron in the laboratory of Dr. Jim McWhir and colleagues at the Roslin Institute in Edinburgh, Scotland demonstrates that osteoblasts (bone-forming cells) can be derived in vitro from hESCs. Such hESC-derived osteoblasts have potential applications in orthopedic tissue repair and in the treatment of osteoporosis.
The research was published in the summer 2003 issue of Cloning and Stem Cells.
The published study demonstrates that hESCs,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.